rs41278359

Variant summary

Our verdict is Benign. The variant received -8 ACMG points: 0P and 8B. BP4_ModerateBP6BP7BS2

The NM_003640.5(ELP1):​c.1230G>A​(p.Pro410Pro) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00735 in 1,614,018 control chromosomes in the GnomAD database, including 64 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).

Frequency

Genomes: 𝑓 0.0069 ( 11 hom., cov: 32)
Exomes 𝑓: 0.0074 ( 53 hom. )

Consequence

ELP1
NM_003640.5 synonymous

Scores

3

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:2B:7

Conservation

PhyloP100: -0.192

Publications

4 publications found
Variant links:
Genes affected
ELP1 (HGNC:5959): (elongator acetyltransferase complex subunit 1) The protein encoded by this gene is a scaffold protein and a regulator for three different kinases involved in proinflammatory signaling. The encoded protein can bind NF-kappa-B-inducing kinase and I-kappa-B kinases through separate domains and assemble them into an active kinase complex. Mutations in this gene have been associated with familial dysautonomia. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jan 2016]
ELP1 Gene-Disease associations (from GenCC):
  • primary dysautonomia
    Inheritance: AR Classification: DEFINITIVE Submitted by: Myriad Women's Health
  • Riley-Day syndrome
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • medulloblastoma
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

new If you want to explore the variant's impact on the transcript NM_003640.5, check out the Mutation Effect Viewer. This is especially useful for frameshift variants or if you want to visualize the effect of exon loss / intron retention.

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -8 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.31).
BP6
Variant 9-108911140-C-T is Benign according to our data. Variant chr9-108911140-C-T is described in ClinVar as Conflicting_classifications_of_pathogenicity. ClinVar VariationId is 137573.
BP7
Synonymous conserved (PhyloP=-0.192 with no splicing effect.
BS2
High Homozygotes in GnomAd4 at 11 AD,AR gene

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003640.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ELP1
NM_003640.5
MANE Select
c.1230G>Ap.Pro410Pro
synonymous
Exon 12 of 37NP_003631.2
ELP1
NM_001318360.2
c.888G>Ap.Pro296Pro
synonymous
Exon 12 of 37NP_001305289.1A0A6Q8PGW3
ELP1
NM_001330749.2
c.183G>Ap.Pro61Pro
synonymous
Exon 10 of 35NP_001317678.1F5H2T0

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
ELP1
ENST00000374647.10
TSL:1 MANE Select
c.1230G>Ap.Pro410Pro
synonymous
Exon 12 of 37ENSP00000363779.5O95163
ELP1
ENST00000537196.1
TSL:1
c.183G>Ap.Pro61Pro
synonymous
Exon 5 of 30ENSP00000439367.1F5H2T0
ELP1
ENST00000495759.6
TSL:1
n.553-2736G>A
intron
N/AENSP00000433514.2H0YDF3

Frequencies

GnomAD3 genomes
AF:
0.00695
AC:
1056
AN:
152042
Hom.:
11
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00150
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00517
Gnomad ASJ
AF:
0.000864
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00104
Gnomad FIN
AF:
0.0325
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.00806
Gnomad OTH
AF:
0.00719
GnomAD2 exomes
AF:
0.00733
AC:
1842
AN:
251410
AF XY:
0.00734
show subpopulations
Gnomad AFR exome
AF:
0.00123
Gnomad AMR exome
AF:
0.00321
Gnomad ASJ exome
AF:
0.00129
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0294
Gnomad NFE exome
AF:
0.00853
Gnomad OTH exome
AF:
0.00831
GnomAD4 exome
AF:
0.00739
AC:
10801
AN:
1461858
Hom.:
53
Cov.:
32
AF XY:
0.00722
AC XY:
5254
AN XY:
727228
show subpopulations
African (AFR)
AF:
0.000956
AC:
32
AN:
33480
American (AMR)
AF:
0.00347
AC:
155
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00157
AC:
41
AN:
26134
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39698
South Asian (SAS)
AF:
0.00145
AC:
125
AN:
86256
European-Finnish (FIN)
AF:
0.0283
AC:
1510
AN:
53418
Middle Eastern (MID)
AF:
0.00225
AC:
13
AN:
5768
European-Non Finnish (NFE)
AF:
0.00769
AC:
8546
AN:
1111986
Other (OTH)
AF:
0.00628
AC:
379
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.474
Heterozygous variant carriers
0
569
1138
1706
2275
2844
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
296
592
888
1184
1480
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00694
AC:
1056
AN:
152160
Hom.:
11
Cov.:
32
AF XY:
0.00809
AC XY:
602
AN XY:
74386
show subpopulations
African (AFR)
AF:
0.00149
AC:
62
AN:
41532
American (AMR)
AF:
0.00517
AC:
79
AN:
15286
Ashkenazi Jewish (ASJ)
AF:
0.000864
AC:
3
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00104
AC:
5
AN:
4816
European-Finnish (FIN)
AF:
0.0325
AC:
344
AN:
10570
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
294
European-Non Finnish (NFE)
AF:
0.00806
AC:
548
AN:
67992
Other (OTH)
AF:
0.00712
AC:
15
AN:
2108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
50
99
149
198
248
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00597
Hom.:
4
Bravo
AF:
0.00517
Asia WGS
AF:
0.000289
AC:
1
AN:
3478
EpiCase
AF:
0.00752
EpiControl
AF:
0.00783

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
-
4
not provided (4)
-
-
3
not specified (3)
-
2
-
Familial dysautonomia (2)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.31
CADD
Benign
4.8
DANN
Benign
0.55
PhyloP100
-0.19
Mutation Taster
=100/0
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

MaxEntScan Visualizer can be used to analyze the impact of this mutation on the neighboring sequence.

Publications

Other links and lift over

dbSNP: rs41278359;
hg19: chr9-111673420;
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.